You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
又有超級打新周,高價股、85後劍橋博士抗癌股都來了
格隆匯 10-10 20:51
格隆匯10月10日丨據中國基金報,國慶節後,新股又開始緊鑼密鼓的發行了,這次一週又是罕見的17只新股登臺,不僅滬深交易所14只,還有即將正式亮相的北交所(精選層),又有3只新股發行。這17只新股當中,目前已經確定發行價的,就有70.9元高價的10月12日週二發行的中自科技,科創板新股,環保催化劑股,一簽金額3.55萬元。若是上漲300%,一簽可賺10萬元。還有同樣10月12日發行的科創板新股匯宇製藥,是國內抗腫瘤概念股,發行價38.87元,也值得關注。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account